Table 1.
Laboratory parameters of patients with TAK and healthy controls
| Parameters | Controls (n=78) | TAK patients (n=88) | p Value |
| Age (years) | 36.46±7.23 | 39.35±15.03 | 0.235 |
| Gender (female/male) | 68/10 | 78/10 | 0.774 |
| WBC (109/L) | 5.53±1.60 | 7.43±2.88 | 0.000 |
| LY (109/L) | 1.72±0.46 | 1.81±0.73 | 0.342 |
| NE (109/L) | 3.37±1.29 | 4.97±2.44 | 0.000 |
| PLT (109/L) | 247.21±45.49 | 241.82±79.69 | 0.387 |
| MPV (fL) | 10.21±0.98 | 10.37±0.97 | 0.269 |
| PDW % | 12.43±1.73 | 11.98±1.95 | 0.052 |
| ALT (U/L) | 15.40±8.94 | 17.00±12.48 | 0.152 |
| BUN (mmol/L) | 5.31±2.01 | 5.52±3.29 | 0.177 |
| Cr (μmol/L) | 63.87±10.47 | 75.57±14.37 | 0.422 |
| ESR (mm/hour) | 4.39 (2.00–12.00) | 19.62 (1.00–92.00) | 0.000 |
| hs-CRP (mg/L) | 0.63 (0.08–2.30) | 9.50 (0.08–38.62) | 0.000 |
| NLR | 2.01±0.89 | 3.86±3.28 | 0.001 |
| PLR | 149.58±39.65 | 167.44±76.58 | 0.023 |
ALT, alanine aminotransferase; BUN, blood urea nitrogen; Cr, creatinine; ESR, erythrocyte sedimentation rate; hs-CRP, high-sensitivity C-reactive protein;LY, lymphocyte; MPV, mean platelet volume; NE, neutrophil; NRL, neutrophil-to-lymphocyte ratio; PDW, platelet distribution width; PLR, platelet-to-lymphocyte ratio; PLT, platelet; n, number of patients; TAK, Takayasu’s arteritis; WBC, white blood cell.